HealthGSK says Greater Bay Area patient data could improve healthcare policy

British drugmaker GSK is using patient data from 88 million people across the Greater Bay Area’s 11 cities to accelerate drug development in vaccines and cancer care. Its Hong Kong and Macau general manager said the data could provide supplementary evidence for regulatory filings and possible label expansions, while helping identify other benefits.

GSKGreater Bay Areapatient datahealthcare policy

SSouth China Morning Post★★☆☆☆2026-09-14 04:59Original